SCHEMBL4090435

SCHEMBL4090435

CCCS(=O)(=O)c1ccc2[nH]c(NC(=O)c3cscn3)nc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 1/20 0.50
RPS6KA2 Q15349 1/20 0.44
ROCK2 O75116 1/20 0.41
MAP3K5 Q99683 1/20 0.40
POLB P06746 2/20 0.39
SMN1; SMN2 Q16637 5/20 0.39
KDM4E B2RXH2 4/20 0.39
HTT P42858 4/20 0.39
LMNA P02545 3/20 0.39
TDP1 Q9NUW8 2/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
ALDH1A1 P00352 2/20 0.39
CYP2C9 P11712 4/20 0.39
CYP2C19 P33261 3/20 0.39
CYP1A2 P05177 2/20 0.39
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28209330 0.81 IRAK4 (0.53) IRAK4RPS6KA2ROCK2SMN1; SMN2KDM4E
SCHEMBL12684800 0.79 LMNA (0.56) IRAK4RPS6KA2ROCK2SMN1; SMN2KDM4E
SCHEMBL418190 0.76 SMN1; SMN2 (0.52) IRAK4SMN1; SMN2KDM4EHTTLMNA
SCHEMBL418792 0.75 NPC1 (0.60) SMN1; SMN2KDM4ELMNANPC1RAB9A
SCHEMBL25956592 0.74 IRAK4 (0.86) IRAK4RPS6KA2POLBSMN1; SMN2NPC1
SCHEMBL19446745 0.74 GRM1 (0.43) ROCK2MAP3K5SMN1; SMN2NPC1RAB9A
SCHEMBL421032 0.73 SCD (0.58) SMN1; SMN2KDM4EHTTLMNANPC1
SCHEMBL2187248 0.73 CSNK1E (0.66) IRAK4ROCK2POLBSMN1; SMN2KDM4E
SCHEMBL11666980 0.71 TUBB4A (0.57) IRAK4SMN1; SMN2HTTLMNANPC1
SCHEMBL15944959 0.70 LPAR2 (0.57) IRAK4CYP2C9CYP2C19CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7601745-B2 Heterocyclic NF-kB inhibitors 4SC AG (DE) 2009-10-13 US disclosed